Partner Article
Teesside University biochem spin-out venture moves into Redcar’s Wilton Centre
TeeGene Biotech, a spin-out venture from Teesside University, has taken up space at the Wilton Centre after taking part in the icreate entrepreneurs programme.
The firm, which carries out biochemical research, is also exploring anti-ageing product, TeeGene Biotech, targeted at the cosmetics industry.
Dr Pattanathu Rahman, founding director of TeeGene Biotech, is a Senior Lecturer in Process Engineering and Biotechnology at Teesside University with 20 years of research experience.
Dr Rahman said: “The EU has established a market for biosurfactants, with an estimated demand of 679 million Euros last year corresponding to half of the global demand.
“The predicted value for biosurfactant market is 1.8 billion Euros by 2030, which is a 300% increase,”
“We are a research-led company, looking to widen the variety of known biosurfactants and bring these to market.
“We want to develop the application area for which biosurfactants are used and branch into other industries. We also lease our platform out to enable access via a franchise model. This enables wider geographical implementation, allowing manufacture in other parts of the world, reducing the carbon footprint associated with transportation.”
This was posted in Bdaily's Members' News section by Ellen Forster .
Enjoy the read? Get Bdaily delivered.
Sign up to receive our daily bulletin, sent to your inbox, for free.
Ready to scale? Buy-and-build offers opportunity
When will our regional economy grow?
Creating a thriving North East construction sector
Why investors are still backing the North East
Time to stop risking Britain’s family businesses
A year of growth, collaboration and impact
2000 reasons for North East business positivity
How to make your growth strategy deliver in 2026
Powering a new wave of regional screen indies
A new year and a new outlook for property scene
Zero per cent - but maximum brand exposure
We don’t talk about money stress enough